Pages that link to "Q48270863"
Jump to navigation
Jump to search
The following pages link to Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc (Q48270863):
Displaying 27 items.
- The Emerging Role for Zinc in Depression and Psychosis (Q33857369) (← links)
- Zinc and the immune system (Q33928055) (← links)
- Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex (Q34466775) (← links)
- Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology (Q35770190) (← links)
- Antioxidants as potential therapeutics for neuropsychiatric disorders (Q36736055) (← links)
- Analysis of Relations Between the Level of Mg, Zn, Ca, Cu, and Fe and Depressiveness in Postmenopausal Women (Q37642198) (← links)
- Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. (Q37681012) (← links)
- Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy (Q38151373) (← links)
- Zinc as a marker of affective disorders (Q38189552) (← links)
- Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats (Q42602477) (← links)
- Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus (Q42945732) (← links)
- Antidepressant-like properties of zinc in rodent forced swim test (Q43685912) (← links)
- Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. (Q44567452) (← links)
- Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment (Q44669675) (← links)
- Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors. (Q45049140) (← links)
- Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims. (Q45153786) (← links)
- Early lifetime zinc supplementation protects zinc-deficient diet-induced alterations (Q45373076) (← links)
- Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression (Q46956639) (← links)
- Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression (Q47686052) (← links)
- Differential Effects of Low- and High-dose Zinc Supplementation on Synaptic Plasticity and Neurogenesis in the Hippocampus of Control and High-fat Diet-fed Mice. (Q47946167) (← links)
- Effect of electroacupuncture on serum copper, zinc, calcium and magnesium levels in the depression rats (Q48224640) (← links)
- Zinc deficiency alters responsiveness to antidepressant drugs in mice (Q48436906) (← links)
- Zinc Improves Cognitive and Neuronal Dysfunction During Aluminium-Induced Neurodegeneration (Q49029449) (← links)
- Effects of Aqueous Extracts of Chicory and Milk Thistle on Serum Concentrations of Copper, Zinc, and Manganese in Tamoxifen-Treated Rats. (Q50931252) (← links)
- Alterations of serum macro-minerals and trace elements are associated with major depressive disorder: a case-control study. (Q55012113) (← links)
- Ionic Glutamate Modulators in Depression (Zinc, Magnesium) (Q60473680) (← links)
- Serum trace elements in animal models and human depression. Part II. Copper (Q60473705) (← links)